Your browser doesn't support javascript.
loading
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment.
Rosswog, Carolina; Schmidt, Rene; Oberthuer, André; Juraeva, Dilafruz; Brors, Benedikt; Engesser, Anne; Kahlert, Yvonne; Volland, Ruth; Bartenhagen, Christoph; Simon, Thorsten; Berthold, Frank; Hero, Barbara; Faldum, Andreas; Fischer, Matthias.
Afiliación
  • Rosswog C; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Schmidt R; Institute of Biostatistics and Clinical Research, University of Muenster, Schmeddingstrasse 56, 48149 Münster, Germany.
  • Oberthuer A; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Juraeva D; Department of Applied Bioinformatics, German Cancer Research Center, Berliner Strasse 41, 69120 Heidelberg, Germany.
  • Brors B; Department of Applied Bioinformatics, German Cancer Research Center, Berliner Strasse 41, 69120 Heidelberg, Germany.
  • Engesser A; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Kahlert Y; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Volland R; Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Bartenhagen C; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Simon T; Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Berthold F; Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Hero B; Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
  • Faldum A; Institute of Biostatistics and Clinical Research, University of Muenster, Schmeddingstrasse 56, 48149 Münster, Germany.
  • Fischer M; Department of Experimental Pediatric Oncology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany; Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany; Center for Molecular Medic
Neoplasia ; 19(12): 982-990, 2017 Dec.
Article en En | MEDLINE | ID: mdl-29091799
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína Proto-Oncogénica N-Myc / Neuroblastoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína Proto-Oncogénica N-Myc / Neuroblastoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos